Daclatasvir/sofosbuvir and ribavirin 800mg flat dose is highly efficacy and safe in genotype 3 compensated and decompensated cirrhotic patients: The CLEO experience
Titel:
Daclatasvir/sofosbuvir and ribavirin 800mg flat dose is highly efficacy and safe in genotype 3 compensated and decompensated cirrhotic patients: The CLEO experience
Auteur:
Pellicelli, A. Messina, V. Tarquini, P. Pace Palitti, V. Ceccherini Silberstein, F. Pompili, M. Gulminetti, R. Cerasari, G. D’Ambrosio, C. Villani, R. Fondacaro, L. Dell’isola, S. Babudieri, S. Iovinella, V. Di Candilo, F. Chiesara, F. Di Maio, V.C. Ponziani, F.R. Sacco, R. Izzi, A. Moretti, A. Giannelli, V. Perno, C.F. Barbarini, G.